DÄ internationalArchiveReferences
References

Clinical Practice Guideline

The Treatment of Depressive Disorders in Children and Adolescents

Dtsch Arztebl Int 2013; 110(50): 854-60. DOI: 10.3238/arztebl.2013.0854

Dolle, K; Schulte-Körne, G

1. WHO: Depression. 2012. www.who.int/mental_health/management/depression/] (last accessed on 20. October 2013).
2.Essau CA: Frequency and patterns of mental health services utilization among adolescents with anxiety and depressive disorders. Depress Anxiety 2005; 22: 130–7. CrossRef MEDLINE
3.Dolle K, Schulte-Körne G: Leitlinie Behandlung von depressiven Störungen bei Kindern und Jugendlichen. www.awmf.org/uploads/tx_szleitlinien/028–043l_S3_Depressive_St%C3% B6rungen_bei_Kindern_Jugendlichen_2013–07.pdf (last accessed on 20. October 2013).
4.National Collaborating Centre for Mental Health: Depression in children and young people. Identification and management in primary, community and secondary care. London: The British Psychological Society & The Royal College of Psychiatrists 2005. www.nice.org.uk/nicemedia/pdf/cg028fullguideline.pdf (last accessed on 20. October 2013).
5.US Preventive Services Task Force: Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force recommendation statement. Pediatrics 2009; 123: 1223–8. CrossRef MEDLINE
6.Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein RE: Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics 2007; 120: e1313–26. CrossRef MEDLINE
7.Zuckerbrot RA, Cheung AH, Jensen PS, Stein RE, Laraque D: Guidelines for adolescent depression in primary care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics 2007; 120: e1299–312. CrossRef MEDLINE
8.Oxford Centre for Evidence-Based Medicine (OCEBM): Levels of evidence working group. The Oxford 2011 Levels of Evidence. 2011 /www.cebm.net/index.aspx?o=5653] (last accessed on 20. October 2013).
9.Remschmidt H, Schmidt MH, Poustka F: Multiaxiales Klassifikationsschema für psychische Störungen des Kindes- und Jugendalters nach ICD-10 der WHO. 5 ed. Bern: Verlag Hans Huber 2006.
10.Watanabe N, Hunot V, Omori IM, Churchill R, Furukawa TA: Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatr Scand 2007; 116: 84–95. CrossRef MEDLINE
11.Harrington R, Whittaker J, Shoebridge P, Campbell F: Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. BMJ 1998; 316: 1559–63. CrossRef MEDLINE
12.Dubicka B, Elvins R, Roberts C, Chick G, Wilkinson P, Goodyer IM: Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010; 197: 433–40. CrossRef MEDLINE
13.Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, et al.: Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database of Systematic Reviews 2012; 11: CD008324. MEDLINE
14.Arzneimittelkommision der deutschen Ärzteschaft: Depression. Therapieempfehlungen der Arzneimittelkommision der deutschen Ärzteschaft. 2. Auflage. Arzneiverordnungen in der Praxis, Band 33, Sonderheft 1 (Therapieempfehlungen) 2006.
e1.Costello EJ, Erkanli A, Angold A: Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 2006; 47: 1263–71. MEDLINE
e2.Emslie GJ, Rush AJ, Weinberg WA, et al.: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54: 1031–7. CrossRef MEDLINE
e3. Härter M, Klesse C, Bermejo I, Schneider F, Berger M: Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline. Dtsch Arztebl Int 2010; 107: 700–8. VOLLTEXT
e4. Hetrick SE, et al.: Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2012; DOI: 10.1002/14651858.CD004851.pub3. CrossRef MEDLINE
e5.Horn H, et al.: Zur Wirksamkeit psychodynamischer Kurzzeitpsychotherapie bei Kindern und Jugendlichen mit Depressionen. Prax Kinderpsychol Kinderpsychiatr 2005; 54: 578–97.
e6.Muratori F, et al.: A Two-Year Follow-up of Psychodynamic Psychotherapy for Internalizing Disorders in Children. J Am Acad Child Adolesc Psychiatry 2003; 42: 331–9. CrossRef MEDLINE
e7.Trowell J, et al.: Childhood depression: a place for psychotherapy. An outcome study comparing individual psychodynamic psychotherapy and family therapy. Eur Child Adolesc Psychiatry 2007; 16: 157–67. CrossRef MEDLINE
e8.Diamond GS, et al.: Attachment-based family therapy for depressed adolescents: a treatment development study. J Am Acad Child Adolesc Psychiatry 2002; 41: 1190–6. CrossRef MEDLINE
e9.von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hulten A: A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006; 26: 311–5. CrossRef MEDLINE
e10.Hazell P, et al.: Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002: CD002317. MEDLINE
e11.Maneeton N, Srisurapanont M: Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials. J Med Assoc Thai 2000; 83: 1367–74. MEDLINE
e12.Papanikolaou K, et al.: Efficacy of antidepressants in child and adolescent depression: a meta-analytic study. J Neural Transm 2006; 113: 399–415. CrossRef MEDLINE
e13.Tsapakis EM, et al.: Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008; 10–7. CrossRef MEDLINE
e14.Moreno C, et al.: Antidepressants in child and adolescent depression: where are the bugs? Acta Psychiatr Scand 2007; 115: 184–95. CrossRef MEDLINE
e15.Avci A, et al.: Comparison of moclobemide and placebo in young adolescents with major depressive disorder. Annals of Medical Sciences 1999; 8: 31–40.
e16.Emslie GJ, et al.: Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004; 43: 1397–405. CrossRef MEDLINE
e17. Emslie GJ, et al.: Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008; 165: 459–67. CrossRef MEDLINE PubMed Central
e18.Kroll LEO, et al.: Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1996; 35: 1156–61. CrossRef MEDLINE
e19.Ghaziuddin N, et al.: Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression. J Child Adolesc Psychopharmacol 1996; 6: 259–71. CrossRef MEDLINE
e20.Ghaziuddin N, Laughrin D, Giordani B: Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 2000; 10: 269–76. CrossRef MEDLINE
e21.Willoughby CL, Hradek EA, Richards NR: Use of electroconvulsive therapy with children: an overview and case report. J Child Adolesc Psychiatr Nurs 1997; 10: 11–7. CrossRef MEDLINE
e22.Rossmann P: Depressionstest für Kinder (DTK). Göttingen: Hogrefe 2005.
e23. Döpfner M, Lehmkuhl G: Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10/DSM-IV. Göttingen: Hogrefe 2000.
e24.Schneider S, Unnewehr S, Margraf J: Kinder-DIPS – Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter [Kinder-DIPS—diagnostic interview for mental disorders in children and youths]. (3rd ed.). Heidelberg: Springer Verlag 2009.
e25.Kennard BD, et al.: Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry 2008; 47: 1395–404. CrossRef MEDLINE PubMed Central
e26.Almeida-Montes LG, Friederichsen A: Treatment of major depressive disorder with fluoxetine in children and adolenscents. A double-blind, placebo-controlled study. Psiquiatria Biologica 2005; 12: 198–205.
e27.Emslie GJ, Heiligenstein JH, Wagner KD, et al.: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41: 1205–15. CrossRef MEDLINE
e28.Simeon JG, Dinicola VF, Ferguson HB, Copping W: Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14: 791–5. CrossRef MEDLINE
e29. March JS: Treatment for Adolescents With Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Treatment for Adolescents With Depression Study (TADS). Randomized controlled trial. JAMA 2004; 292: 807–20. CrossRef MEDLINE
e30.Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S: Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009; 48: 721–9. CrossRef MEDLINE
e31.Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K: A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006; 45: 280–8. CrossRef MEDLINE
e32.Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004; 161: 1079–83. CrossRef MEDLINE
e33.Wagner KD, Ambrosini P, Rynn M, et al.: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003; 290: 1033–41. CrossRef MEDLINE